These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34797014)

  • 1. Evaluation of lymphocyte-specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
    Pinard CJ; Stegelmeier AA; Bridle BW; Mutsaers AJ; Wood RD; Wood GA; Woods JP; Hocker SE
    Vet Comp Oncol; 2022 Jun; 20(2):427-436. PubMed ID: 34797014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
    Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H
    Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma.
    Setyo LC; Donahoe SL; Shearer PL; Wang P; Krockenberger MB
    J Vet Diagn Invest; 2023 Mar; 35(2):109-115. PubMed ID: 36648148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines.
    Pinard CJ; Hocker SE; Poon AC; Inkol JM; Matsuyama A; Wood RD; Wood GA; Woods JP; Mutsaers AJ
    Vet Immunol Immunopathol; 2022 Jan; 243():110367. PubMed ID: 34923192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
    Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM
    BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 expression by canine T cells and functional effects of PD-1 blockade.
    Coy J; Caldwell A; Chow L; Guth A; Dow S
    Vet Comp Oncol; 2017 Dec; 15(4):1487-1502. PubMed ID: 28120417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder.
    Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T
    Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
    Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T
    Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1
    Batorov EV; Ineshina AD; Aristova TA; Denisova VV; Sizikova SA; Batorova DS; Ushakova GY; Shevela EY; Chernykh ER
    Oncol Res; 2024; 32(10):1575-1587. PubMed ID: 39308517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the current standing of microRNA expression in canine urothelial carcinoma.
    Varvil MS; Dos Santos AP
    Am J Vet Res; 2024 Oct; 85(10):. PubMed ID: 39047791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Checkpoint Inhibition in Localized Bladder Cancer.
    Hahn NM; Necchi A; Loriot Y; Powles T; Plimack ER; Sonpavde G; Roupret M; Kamat AM
    Eur Urol Oncol; 2018 Aug; 1(3):190-198. PubMed ID: 31102620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
    Calvalido J; Wood GA; Mutsaers AJ; Wood D; Sears W; Woods JP
    Vet Immunol Immunopathol; 2016 Dec; 182():106-114. PubMed ID: 27863540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder.
    Tosev G; Wahafu W; Reimold P; Damgov I; Schwab C; Aksoy C; Kaczorowski A; Stenzinger A; Nyarangi-Dix J; Hohenfellner M; Duensing S
    Sci Rep; 2021 Jul; 11(1):14244. PubMed ID: 34244564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
    Vinall RL; Kent MS; deVere White RW
    Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy.
    Shi LZ; Fu T; Guan B; Chen J; Blando JM; Allison JP; Xiong L; Subudhi SK; Gao J; Sharma P
    Nat Commun; 2016 Aug; 7():12335. PubMed ID: 27498556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis.
    Hou L; Jie Z; Liang Y; Desai M; Soong L; Sun J
    Cell Mol Immunol; 2015 Mar; 12(2):213-21. PubMed ID: 25027969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.